Skip to content

Saku Control Obesity Program

Saku Control Obesity Program - SCOP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016892
Enrollment
200
Registered
2015-03-25
Start date
2006-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Lifestyle intervention (diet and exercise) No intervention

Sponsors

Incorporated Administrative Agency National Institute of Health and Nutrition
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Underwent a medical checkup in the Saku Central Hospital since 2000. 2) Body mass index at the most recent visits greater than 28.3 kg/m2 (the upper five percentile of all examinees).

Exclusion criteria

Exclusion criteria: 1) Psychiatric conditions that would preclude full participation in the study. 2) Physical conditions that would preclude full participation in the study (i.e., significant hepatic or renal dysfunction and significant cardiovascular disease such as heart failure, stroke, and transient ischemic attacks). 3) Currently receiving treatment for obesity. 4) Currently receiving treatments known to affect eating behavior or weight.

Design outcomes

Primary

MeasureTime frame
Body weight

Secondary

MeasureTime frame
Body mass index(BMI), height, percent body fat, weight circumference, visceral fat area, subcutaneous fat area, blood pressure, biochemical measurements (blood glucose, serum lipids, blood biomarkers, urine biomarkers), dietary intakes, eating behavior (appetite, taste), energy expenditure, basal metabolic rate, physical activity levels, personality inventory, and disease incidence

Countries

Japan

Contacts

Public ContactAkemi Morita

Koshien University Department of Nutrition

a-morita@koshien.ac.jp0797-87-8078

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026